GUMDROP : JHMI J1099 A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy and safety of pazopanib as adjuvant therapy for subjects with localized or locally advanced RCC following nephrectomy
Created by Channing Paller, last modified by Nancy Dawson on Apr 28, 2013
Description: | RCC with clear-cell or predominant clear-cell histology; non-metastatic dx (M0) with pT2/G3 or G4/N0; or pT3/Gany/N0; or pT4/Gany/N0; or pTany/Gany/N1; completed nephrectomy w/i 12 weeks of registration |
Link: | http://clinicaltrials.gov/ct2/show/study/NCT01235962 | |
Site: | Johns Hopkins Hospital |
Principal Investigator: | Hans Hammers, M.D. |